• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

一种用于术前标记不可触及乳腺病变的立体定向技术。

A stereotaxic technique for preoperative marking of non-palpable breast lesions.

作者信息

Svane G

出版信息

Acta Radiol Diagn (Stockh). 1983;24(2):145-51. doi: 10.1177/028418518302400207.

DOI:10.1177/028418518302400207
PMID:6353873
Abstract

A new method for preoperative marking has been evaluated in 56 non-palpable lesions of the breast. With the aid of a stereotaxic biopsy instrument the lesion is located and an aqueous suspension of carbon particles is injected so as to leave a distinct trail from the lesion out to the skin. This trail gives precise guidance to the site of the lesion, facilitating the removal of a minimum volume of tissue. According to current experience, the carbon does not diffuse into surrounding tissues and therefore the marking can be done well in advance of surgery.

摘要

一种术前标记的新方法已在56例乳腺不可触及病变中进行了评估。借助立体定向活检仪器定位病变，然后注射碳颗粒水悬液，以便从病变处到皮肤留下明显的痕迹。这条痕迹为病变部位提供了精确的引导，有助于切除最小体积的组织。根据目前的经验，碳不会扩散到周围组织中，因此标记可以在手术前很久就完成。

相似文献

1
A stereotaxic technique for preoperative marking of non-palpable breast lesions.一种用于术前标记不可触及乳腺病变的立体定向技术。
Acta Radiol Diagn (Stockh). 1983;24(2):145-51. doi: 10.1177/028418518302400207.
2
[Preoperative marking of non-palpable breast lesions by the stereotaxic tattooing and "harpoon" technique. 670 cases].[应用立体定向纹身和“鱼叉”技术对不可触及乳腺病变进行术前标记。670例病例]
J Gynecol Obstet Biol Reprod (Paris). 1994;23(3):259-63.
3
Marking of nonpalpable breast lesions using a custom carbon suspension.使用定制的碳悬浮液对不可触及的乳腺病变进行标记。
Acta Radiol. 2001 Nov;42(6):599-601. doi: 10.1080/028418501127347269.
4
Prebiopsy localization of non-palpable breast cancer.不可触及乳腺癌的活检前定位
J Belge Radiol. 1990 Oct;73(5):401-4.
5
[The stereotaxic localization of the smallest breast lesions for diagnosis and preoperative marking--the methods, experimental studies and clinical results with 217 patients].[用于诊断及术前标记的最小乳腺病变的立体定向定位——方法、实验研究及217例患者的临床结果]
Rofo. 1992 Mar;156(3):286-90. doi: 10.1055/s-2008-1032884.
6
Lesions entirely removed during stereotactic biopsy: preoperative localization on the basis of mammographic landmarks and feasibility of freehand technique--initial experience.立体定向活检中完全切除的病变：基于乳腺X线摄影标记的术前定位及徒手技术的可行性——初步经验
Radiology. 2000 Feb;214(2):585-90. doi: 10.1148/radiology.214.2.r00ja18585.
7
Svane localisation of non-palpable breast lesions.
Lancet. 1991 Sep 28;338(8770):816. doi: 10.1016/0140-6736(91)90696-m.
8
[The preoperative marking of nonpalpable breast lesions: the technic and results].
Rofo. 1992 Nov;157(5):512-7. doi: 10.1055/s-2008-1033051.
9
Clip placement facilitating the approach to breast lesions.
Eur Radiol. 2002 Feb;12(2):471-4. doi: 10.1007/s003300101006. Epub 2001 Aug 9.
10
The role of stereotaxic fine needle biopsy in non-palpable breast lesions.立体定向细针穿刺活检在不可触及乳腺病变中的作用。
J Belge Radiol. 1990 Oct;73(5):395-9.

引用本文的文献

1
Innovations in the localization techniques for non-palpable breast lesions: Make invisible visible.不可触及乳腺病变定位技术的创新：让不可见变为可见。
Breast. 2025 Jun;81:104430. doi: 10.1016/j.breast.2025.104430. Epub 2025 Feb 26.
2
Oncological outcomes of selective axillary dissection with 4% carbon marking.4%碳标记选择性腋窝清扫术的肿瘤学结果。
Rev Col Bras Cir. 2024 Nov 25;51:e20243697. doi: 10.1590/0100-6991e-20243697-en. eCollection 2024.
3
Resection Ratios and Tumor Eccentricity in Breast-Conserving Surgery Specimens for Surgical Accuracy Assessment.
保乳手术标本中的切除率和肿瘤偏心度用于手术准确性评估
Cancers (Basel). 2024 May 9;16(10):1813. doi: 10.3390/cancers16101813.
4
Effectiveness of Carbon Localization for Invasive Breast Cancer: An Institutional Experience.碳定位在浸润性乳腺癌中的有效性：机构经验。
Breast J. 2023 Jul 18;2023:4082501. doi: 10.1155/2023/4082501. eCollection 2023.
5
The efficacy and safety of an indocyanine green-hyaluronic acid mixture (LuminoMark™) for localization in patients with non-palpable breast lesions: A multicenter, randomized, open-label, parallel phase 3 clinical trial.吲哚菁绿-透明质酸混合物（LuminoMark™）用于不可触及乳腺病变患者定位的疗效和安全性：一项多中心、随机、开放标签、平行3期临床试验。
Front Oncol. 2023 Mar 24;13:1039670. doi: 10.3389/fonc.2023.1039670. eCollection 2023.
6
Localization Techniques for Non-Palpable Breast Lesions: Current Status, Knowledge Gaps, and Rationale for the MELODY Study (EUBREAST-4/iBRA-NET, NCT 05559411).不可触及乳腺病变的定位技术：现状、知识空白及MELODY研究（EUBREAST-4/iBRA-NET，NCT 05559411）的理论依据
Cancers (Basel). 2023 Feb 12;15(4):1173. doi: 10.3390/cancers15041173.
7
and () Downregulation by Neoadjuvant Therapy is Associated with Better Therapeutic Outcomes and Survival in Breast Cancer.新辅助治疗引起的（基因）下调与乳腺癌更好的治疗效果和生存率相关。 （括号内“基因”为补充内容，使句子更通顺，根据英文推测原文可能想表达这个意思，但题目要求不添加其他任何解释或说明，所以可根据实际情况调整）
J Oncol. 2022 Nov 28;2022:6001947. doi: 10.1155/2022/6001947. eCollection 2022.
8
Evaluation of Carbon Nanoparticle Suspension and Methylene Blue Localization for Preoperative Localization of Nonpalpable Breast Lesions: A Comparative Study.碳纳米颗粒悬浮液与亚甲蓝定位用于不可触及乳腺病变术前定位的评估：一项对比研究
Front Surg. 2021 Nov 23;8:757694. doi: 10.3389/fsurg.2021.757694. eCollection 2021.
9
Options to Determine Pathological Response of Axillary Lymph Node Metastasis after Neoadjuvant Chemotherapy in Advanced Breast Cancer.确定晚期乳腺癌新辅助化疗后腋窝淋巴结转移病理反应的方法
Cancers (Basel). 2021 Aug 19;13(16):4167. doi: 10.3390/cancers13164167.
10
Preoperative non-palpable breast lesion localization, innovative techniques and clinical outcomes in surgical practice: A systematic review and meta-analysis.术前不可触及的乳腺病变定位，手术实践中的创新技术和临床结果：系统评价和荟萃分析。
Breast. 2021 Aug;58:93-105. doi: 10.1016/j.breast.2021.04.007. Epub 2021 Apr 22.